Publications by authors named "Javier Aller"

Claim this Profile
E
Executive summary of the consensus document for the management of severe Cushing's syndrome: Consensus document of the Neuroendocrinology Focus Group of the Spanish Society of Endocrinology and Nutrition (SEEN).
Marta Araujo-Castro, Rogelio García-Centeno, Javier Aller, Mónica Marazuela, Alfonso Soto

Endocrinol Diabetes Nutr (Engl Ed)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arsenome, Arsenobolome, and Arsenobiolome.
Fernando J Pereira, Roberto López, A Javier Aller

Int J Mol Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and treatment patterns of advanced and radioiodine-refractory differentiated thyroid cancer. ERUDIT study.
Carlos López López, Marcel Sambo, Lorenzo Orcajo-Rincon, Manuel Durán-Poveda, Julio Rodríguez-Villanueva García, Javier Aller

Clin Transl Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of the S-GRAS score for predicting recurrence in patients with adrenocortical carcinoma: implications for adjuvant mitotane therapy.
Paula Jimenez-Fonseca, Cristina Álvarez-Escola, Inmaculada Ballester Navarro, Jorge Hernando Cubero, Laura González Fernández, Javier Aller

Eur J Endocrinol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Long Journey towards Personalized Targeted Therapy in Poorly Differentiated Thyroid Carcinoma (PDTC): A Case Report and Systematic Review.
Odysseas Violetis, Panagiota Konstantakou, Ariadni Spyroglou, Antonios Xydakis, Panagiotis B Kekis, Javier Aller

J Pers Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrochemical Kinetics and Detection of Paracetamol by Stevensite-Modified Carbon Paste Electrode in Biological Fluids and Pharmaceutical Formulations.
Moaad Gharous, Loubna Bounab, Fernando J Pereira, Mohamed Choukairi, Roberto López, A Javier Aller

Int J Mol Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma.
Bruna Calsina, Elena Piñeiro-Yáñez, Ángel M Martínez-Montes, Eduardo Caleiras, Ángel Fernández-Sanromán, Javier Aller

Nat Commun· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study.
Juan Antonio Vallejo Casas, Marcel Sambo, Carlos López López, Manuel Durán-Poveda, Julio Rodríguez-Villanueva García, Javier Aller

Eur Thyroid J· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pasireotide in the Personalized Treatment of Acromegaly.
Manel Puig-Domingo, Ignacio Bernabéu, Antonio Picó, Betina Biagetti, Joan Gil, Javier Aller

Front Endocrinol (Lausanne)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of an RP-HPLC-PDA Method for Determination of Paracetamol, Caffeine and Tramadol Hydrochloride in Pharmaceutical Formulations.
Fernando J Pereira, Aida Rodríguez-Cordero, Roberto López, Luis C Robles, A Javier Aller

Pharmaceuticals (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline mutations in the new E1' cryptic exon of the gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma.
Alexandre Buffet, Bruna Calsina, Shahida Flores, Sophie Giraud, Marion Lenglet, Javier Aller

J Med Genet· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD133 Expression in Medullary Thyroid Cancer Cells Identifies Patients with Poor Prognosis.
Alfonso Cordero-Barreal, Eduardo Caleiras, Evangelina López de Maturana, María Monteagudo, Ángel M Martínez-Montes, Javier Aller

J Clin Endocrinol Metab· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma.
Bruna Calsina, Luis Jaime Castro-Vega, Rafael Torres-Pérez, Lucía Inglada-Pérez, Maria Currás-Freixes, Javier Aller

Theranostics· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of diabetes mellitus in patients with acromegaly treated with second-line pharmacotherapy in Spain.
Laura Sánchez-Cenizo, Javier Aller, José Manuel Martínez-Sesmero, Nuria Mir, Carmen Peral

Clinicoecon Outcomes Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas.
Laura Remacha, David Pirman, Christopher E Mahoney, Javier Coloma, Bruna Calsina, Javier Aller

Am J Hum Genet· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study.
Rosa Cámara, Eva Venegas, Juan Antonio García-Arnés, Fernando Cordido, Javier Aller

Pituitary· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas.
Laura Remacha, David Pirman, Christopher E Mahoney, Javier Coloma, Bruna Calsina, Javier Aller

Am J Hum Genet· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review.
Enrique Grande, Ángel Díaz, Carlos López, Javier Munarriz, Juan-José Reina, Javier Aller

Ther Adv Endocrinol Metab· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive biomarkers for somatostatin analogs, peptide receptor radionuclide therapy and serotonin pathway targets in neuroendocrine tumours.
Jorge Barriuso, Ana Custodio, Ruth Afonso, Vicente Alonso, Aurora Astudillo, Javier Aller

Cancer Treat Rev· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimisation of treatment with lenvatinib in radioactive iodine-refractory differentiated thyroid cancer.
Jaume Capdevila, Kate Newbold, Lisa Licitra, Aron Popovtzer, Francesc Moreso, Javier Aller

Cancer Treat Rev· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly.
Peter J Trainer, John D C Newell-Price, John Ayuk, Simon J B Aylwin, Aled Rees, Javier Aller

Eur J Endocrinol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Criteria for diagnosis and postoperative control of acromegaly, and screening and management of its comorbidities: Expert consensus.
Ignacio Bernabeu, Javier Aller, Cristina Álvarez-Escolá, Carmen Fajardo-Montañana, Ángeles Gálvez-Moreno

Endocrinol Diabetes Nutr (Engl Ed)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC).
Jaume Capdevila, José Manuel Trigo, Javier Aller, José Luís Manzano, Silvia García Adrián

Eur J Endocrinol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics.
Maria Currás-Freixes, Elena Piñeiro-Yañez, Cristina Montero-Conde, María Apellániz-Ruiz, Bruna Calsina, Javier Aller

J Mol Diagn· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience.
Guillermo Crespo, Paula Jiménez-Fonseca, Ana Custodio, Carlos López, Alberto Carmona-Bayonas, Javier Aller

Future Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis